facultyBanner

Dr. Derajram Benival, Ph.D.

Associate Professor , Department of Pharmaceutics

Research Interest

Research Area

  • Intravitreal implants
  • Long acting injectables
  • Hot Melt Extrusion in Pharmaceuticals
  • Protein and peptide delivery

Experience

  • March 2025 - Present
    Associate Professor

    NIPER- Ahmedabad, Palaj, Gandhinagar

  • March 2020 -March 2025
    Assistant Professor

    NIPER- Ahmedabad, Palaj, Gandhinagar

  • May 2017 - March 2020
    Manager 1

    Formulation Research & Development,Sun Pharmaceutical Industries Ltd.Vadodara

  • March 2015 – May 2017
    Scientist E2 (Pharmaceutics)

    Corporate Research & Development Centre, HLL Lifecare Ltd.,Thiruvananthapuram,Kerala

  • March 2012 - March 2015
    Research Officer

    Formulation Development, Sun Pharma Advanced Research Company Ltd.Mumbai

Research Grant

  1. Title: “Hit to Lead Optimization of Adamantane-Quinoxalone Hybrids for the Precision Chemotherapy of Acute Myeloid Leukemia” (IIRPIG-2025-01-00800).
  2. Investigating Particles of Ciprofloxacin Injection by Otsuka.
  3. Development of long acting testosterone injection by StepsBio India Pvt. Ltd.

Publications

  • Dhwani Rana, Sagar Salave, Derajram Benival. (2021). Emerging trends in Abuse-Deterrent Formulations: Technological insights and Regulatory considerations, Current Drug Delivery. DOI : 10.2174/1567201818666211208101035
  • Dhwani Rana, Sagar Salave, Suraj Longare, Rishabh Agarwal, Kiran Kalia,
    Benival D.M
    . (2021). Nanotherapeutics in Tumour Microenvironment for Cancer Therapy, Nanoscience & Nanotechnology-Asia. DOI : 10.2174/2210681211666210908144839
  • Sagar Salave, Sonali Jain, Ambika Chamoli, Amit Mandoli, Ravi Shah, Kiran Kalia,Benival D.M,. (2020). Role Of Biologicals For Combating Covid-19: A Systematic Review, World Journal Of Pharmacy And Pharmaceutical Sciences,9(12),
    456-484. DOI: 10.20959/wjpps202012-17770
  • Benival D.M, and Devarajan Padma V. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability. International Journal of Pharmaceutics. 2012;423: 554–561 (Impact Factor: 4.213).
  • Benival D.M, and Devarajan Padma V. In situ lipidization as a new approach for the design of a self microemulsifying drug delivery system (SMEDDS) of doxorubicin hydrochloride for oral administration.
    Journal of Biomedical Nanotechnology. 2014; 10:1-10 ((Impact Factor: 5.068).

Research Grant

  1. Title: “Multimetal nanozyme complex, preparation process, and nanoformulation prepared thereof”,
    Application No. 202621076098, 2026.
  2. Title: “Polyherbal component containing slow eroding extrudate for treatment of mouth ulcer”,
    Application No. 202321008552, 2023.
Back to top Back to top